NexPoint, a multibillion-dollar alternative investment firm, today announced the 10-year anniversary of the NexPoint Merger Arbitrage Fund Class Z (HMEZX) (the "Fund"). The Fund is an actively managed ...
Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.